GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:15 2025-12-09 am EST			5-day change	1st Jan Change
1,783.00 ^GBX	-2.06%		-1.98%	+32.42%

12:05pm	GSK : JP Morgan keeps a Sell rating	ZD
12:01pm	Retail drags on FTSE as stocks drift ahead of Fed	AN

Transcript : GSK plc, Q2 2024 Earnings Call, Jul 31, 2024

Published on 07/31/2024 at 07:00 am EDT

S&P Capital IQ

Presenter Speech
Nick Stone (Executives)

Hello, everyone. Welcome to today's call and webcast. The presentation was sent to our distribution list by e-mail today, and you can also find it on gsk.com.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about GSK plc

12:05pm	GSK : JP Morgan keeps a Sell rating	ZD
12:01pm	Retail drags on FTSE as stocks drift ahead of Fed	AN
Dec. 08	JPMorgan cuts M&G, UBS cuts Trainline	AN
Dec. 08	GSK : JP Morgan gives a Sell rating	ZD
Dec. 05	Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns	RE
Dec. 05	Health Rounds: Shingles vaccine reduces risk of death from dementia, study finds	RE
Dec. 05	Kennedy's advisers scrap hepatitis B vaccine guidance for most children in major policy shift	RE
Dec. 04	GSK : UBS sticks Neutral	ZD
Dec. 04	UK stocks rise on boost from industrials and financials	RE
Dec. 04	Kennedy advisers delay vote to drop hepatitis B vaccine recommendation, a major policy shift	RE
Dec. 03	UK Government to Consult Executives from AstraZeneca, GSK on New Drug Pricing Regime	MT
Dec. 02	Sector Update: Health Care Stocks Lower Tuesday Afternoon	MT
Dec. 02	European Equities Close Mixed in Tuesday Trading; Euro Area Inflation Rises 2.2% in November	MT
Dec. 02	AstraZeneca, GSK to Join UK Working Group on New Drug-Pricing Framework	MT
Dec. 02	European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	MT
Dec. 02	Janux dives as gaps in prostate cancer study data worry investors	RE
Dec. 01	US to zero out tariffs on UK pharmaceuticals under trade deal	AN
Dec. 01	GSK: Long-term data from DREAMM-7, DREAMM-8 highlight sustained benefits of belantamab mafodotin in treatment of relapsed/refractory multiple myeloma	RE
Dec. 01	GSK says data at ASH show potential to redefine outcomes for people living with blood cancers	RE
Nov. 28	Sector Update: Health Care Stocks Decline Friday Afternoon	MT
Nov. 28	Sector Update: Health Care	MT
Nov. 28	European Equities Close Out Week Higher in Friday Trading; German, French Inflation Rises	MT
Nov. 28	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week	MT
Nov. 28	AnaptysBio, GSK's Tesaro Unit Likely Settle Jemperli Dispute Before July, Wedbush Says	MT
Nov. 28	Sector Update: Energy Stocks Advance Premarket Friday	MT